
Early and managed access programmes provide opportunities for patients to get the treatments they need faster – but the COVID-19 …

The FDA has made MDMA treatment for PTSD more accessible by putting it on the Expanded Access program. 10 sites …
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care

